SCHEMBL286354

SCHEMBL286354

Cc1cc2c(c(C)c1Br)COC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 7/20 0.46
KCNH2 Q12809 6/20 0.40
ACHE P22303 1/20 0.38
SSTR1 P30872 1/20 0.38
SLC6A4 P31645 1/20 0.38
ALOX5 P09917 5/20 0.36
NUAK1 O60285 1/20 0.36
IGF1R P08069 1/20 0.36
MET P08581 1/20 0.36
PIM1 P11309 1/20 0.36
SRC P12931 1/20 0.36
AXL P30530 1/20 0.36
AKT1 P31749 1/20 0.36
KDR P35968 1/20 0.36
NEK2 P51955 1/20 0.36
PLK1 P53350 1/20 0.36
PTK2 Q05397 1/20 0.36
PKN1 Q16512 1/20 0.36
AURKB Q96GD4 1/20 0.36
NEK6 Q9HC98 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286572 0.84 KCNJ1 (0.41) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL23496685 0.83 KCNJ1 (0.44) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL23513349 0.83 KCNJ1 (0.44) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL23496739 0.83 KCNJ1 (0.47) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL23496743 0.78 CYP1A2 (0.41) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL2894925 0.75 KCNJ1 (0.46) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL298348 0.75 KCNJ1 (0.43) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL286429 0.73 KCNJ1 (0.42) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL2897757 0.73 KCNJ1 (0.40) KCNJ1KCNH2ACHESSTR1SLC6A4
SCHEMBL286899 0.73 KCNJ1 (0.60) KCNJ1KCNH2ACHESSTR1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427444-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2015-12-16 EP disclosed
US-9018211-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. (US) 2015-04-28 US disclosed
US-20140142115-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2014-05-22 US disclosed
US-8673920-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. (US) 2014-03-18 US disclosed
EP-2427444-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2012-03-14 EP disclosed
WO-2010129379-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2010-11-11 WO disclosed
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142115-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 KCNJ1 2/4885KCNH2 16/4885ACHE 4836/4885
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 KCNJ1 2/4885KCNH2 16/4885ACHE 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.